Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
RESEARCH TOOLSreports
Holding SONN?
Track your performance easily
See the Price Targets and Ratings of:
SONN Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SONN Stock 12 Month Forecast
Average Price Target
$240.00
▲(7768.85% Upside)
| Highest Price Target$240.00 | Average Price Target$240.00 | Lowest Price Target$240.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Chardan Capital
Reiterated
08/22/24
Clear Street
$88→$56
Buy
1736.07%
Upside
Reiterated
05/16/24
Sonnet BioTherapeutics price target lowered to $7 from $11 at EF HuttonSonnet BioTherapeutics price target lowered to $7 from $11 at EF Hutton
BTIG
$16
Buy
424.59%
Upside
Reiterated
02/14/24
Buy Recommendation for Sonnet BioTherapeutics: Clinical Progress and Strong Financial Position
Ladenburg Thalmann & Co.
$56
Buy
1736.07%
Upside
Initiated
11/27/23
Sonnet BioTherapeutics initiated with a Buy at LadenburgSonnet BioTherapeutics initiated with a Buy at Ladenburg
Best Analysts Covering Sonnet BioTherapeutics Holdings
Which Analyst Should I Follow If I Want to Buy SONN and Sell After:
1 Month
xxx
Success Rate
5/17 ratings generated profit
Average Return
-5.19%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 29.41% of your transactions generating a profit, with an average return of -5.19% per trade.
3 Months
xxx
Success Rate
4/8 ratings generated profit
Average Return
-14.59%
reiterated a xxx
rating 9 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -14.59% per trade.
1 Year
Success Rate
0/17 ratings generated profit
Average Return
-79.28%
reiterated a buy rating 3 months ago
Copying Keay Nakae's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -79.28% per trade.
2 Years
xxx
Success Rate
0/17 ratings generated profit
Average Return
-91.46%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -91.46% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SONN Analyst Recommendation Trends
Rating
Nov 23
Dec 23
Feb 24
May 24
Aug 24
Strong Buy
2
2
2
2
3
Buy
3
3
2
2
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
4
4
4
Each month's total comprises the sum of three months' worth of ratings.
SONN Financial Forecast
SONN Stock Forecast FAQ
What is SONN’s average 12-month price target, according to analysts?
Based on analyst ratings, Sonnet BioTherapeutics Holdings’s 12-month average price target is $240.00.
What is SONN’s upside potential, based on the analysts’ average price target?
Sonnet BioTherapeutics Holdings has 7768.85% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SONN a Buy, Sell or Hold?
Sonnet BioTherapeutics Holdings has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Sonnet BioTherapeutics Holdings’s price target?
The average price target for Sonnet BioTherapeutics Holdings is $240.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $240.00 ,the lowest forecast is $240.00. The average price target represents 7768.85% Increase from the current price of $3.05.
The highest analyst price target is $240.00 ,the lowest forecast is $240.00. The average price target represents 7768.85% Increase from the current price of $3.05.
What do analysts say about Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of SONN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.